Display options
Cite
Phillip M, Segeve Y, Zung A, et al. The accumulation of IGF-I in kidneys of streptozotocin-diabetic adult rats is not associated with elevated plasma GH or IGF-I levels. Endocrine. 1995;3(9):689-93doi: 10.1007/BF02746346.
Phillip, M., Segeve, Y., Zung, A., Kowarski, A. A., Werner, H., Roberts, C. T., Leroith, D., Ladas, J., & Mulroney, S. E. (1995). The accumulation of IGF-I in kidneys of streptozotocin-diabetic adult rats is not associated with elevated plasma GH or IGF-I levels. Endocrine, 3(9), 689-93. https://doi.org/10.1007/BF02746346
Phillip, M, et al. "The accumulation of IGF-I in kidneys of streptozotocin-diabetic adult rats is not associated with elevated plasma GH or IGF-I levels." Endocrine vol. 3,9 (1995): 689-93. doi: https://doi.org/10.1007/BF02746346
Phillip M, Segeve Y, Zung A, Kowarski AA, Werner H, Roberts CT, Leroith D, Ladas J, Mulroney SE. The accumulation of IGF-I in kidneys of streptozotocin-diabetic adult rats is not associated with elevated plasma GH or IGF-I levels. Endocrine. 1995 Sep;3(9):689-93. doi: 10.1007/BF02746346. PMID: 21153228.
Copy Download .nbib Format: NLM
Share it on

Endocrine. 1995 Sep;3(9):689-93. doi: 10.1007/BF02746346.

The accumulation of IGF-I in kidneys of streptozotocin-diabetic adult rats is not associated with elevated plasma GH or IGF-I levels.

Endocrine

M Phillip, Y Segeve, A Zung, A A Kowarski, H Werner, C T Roberts, D Leroith, J Ladas, S E Mulroney

Affiliations

  1. Department of Pediatrics, Soroka Medical Center, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

PMID: 21153228 DOI: 10.1007/BF02746346

Abstract

Nephropathy is a major complication of diabetes mellitus and is associated with expansion of the mesangium and an increase in kidney size in both humans and rats. Interestingly, early kidney enlargement occurs only in postpubertal animals, and is preceded by a significant increase in the levels of extractable renal IGF-I. This study examined the possibility that this difference is GH dependent, and that very early changes in plasma GH and/or IGF-I in the adult animal are associated with an early accumulation of renal IGF-I. Silastic jugular catheters were placed in adult (13-14 week) male Sprague-Dawley (S-D) rats for blood collection and drug injection. Serial blood samples were taken every 30 min in groups of saline control and streptozotocin (STZ) (50 μg/kg, IV) rats from 1-6 h, 9-15 h, and 24-30 h post-injection, and plasma GH profiles were determined by RIA. Renal IGF-I content was assessed following acid extraction. Following STZ, there was an immediate, step-wise reduction in peak GH levels (saline controls, 54±7 ng/mlvs 30±5 (1-6 h); 23±10 (9-15 h); and 13±3 ng/ml (24-30 h post-STZ);P<0.05 for all STZ groupsvs control). The same significant step-wise reduction was observed in the integrated area under the curve for GH. A separate group of rats were treated with a GH-releasing factor antagonist (GRF-AN) for 5 days prior to STZ, to suppress pulsatile GH release, and reduce plasma IGF-I. Chronic GRF-AN administration reduced plasma IGF-I levels significantly to 63% of control values (P<0.01). However, despite the reduction in plasma IGF-I, renal IGF-I remained significantly elevated 24 h post-STZ compared with controls and not significantly different from animals treated with STZ alone (467±49 ng IGF-I/g KW in control salinevs 778±100 in saline/STZ and 705±87 ng IGF-I/g KW in chronic GRF-AN/STZ rats (P<0.05)). In conclusion, following STZ administration in the adult rat, there is an immediate reduction in GH levels, indicating the renal IGF-I accumulation occurs without initial increases in plasma GH levels. Furthermore, when plasma IGF-I levels in the adult are significantly reduced renal IGF-I content remains elevated. These data suggest that early diabetic renal growth is not associated with elevated circulating GH levels, and that high basal plasma IGF-I levels are not necessary for IGF-I accumulation.

References

  1. Am J Physiol. 1989 Jul;257(1 Pt 2):F29-34 - PubMed
  2. Acta Endocrinol (Copenh). 1982 Jan;99(1):109-11 - PubMed
  3. Clin Sci Mol Med. 1976 Dec;51(6):551-5 - PubMed
  4. Endocrinology. 1981 Jan;108(1):76-82 - PubMed
  5. Proc Natl Acad Sci U S A. 1989 Oct;86(19):7451-5 - PubMed
  6. Endocrinology. 1992 May;130(5):2697-702 - PubMed
  7. N Engl J Med. 1985 Mar 7;312(10):617-21 - PubMed
  8. Diabetologia. 1981 Apr;20(4):451-6 - PubMed
  9. Diabetologia. 1990 Jun;33(6):334-8 - PubMed
  10. Endocrinology. 1987 Feb;120(2):491-6 - PubMed
  11. Diabetes Metab Rev. 1992 Oct;8(3):229-57 - PubMed
  12. Diabetologia. 1980 Jun;18(6):501-5 - PubMed
  13. Proc Natl Acad Sci U S A. 1987 Dec;84(24):8946-50 - PubMed
  14. J Clin Endocrinol Metab. 1980 Oct;51(4):781-8 - PubMed
  15. Endocrinology. 1971 Apr;88(4):1079-82 - PubMed
  16. Endocrinology. 1989 Mar;124(3):1154-9 - PubMed
  17. Diabetologia. 1989 Apr;32(4):261-5 - PubMed
  18. Diabetologia. 1992 Jun;35(6):589-93 - PubMed
  19. Am J Physiol. 1994 Apr;266(4 Pt 2):F628-32 - PubMed
  20. Diabetes. 1990 May;39(5):557-62 - PubMed
  21. Diabetes. 1990 Dec;39(12):1490-7 - PubMed
  22. Biochemistry. 1979 Nov 27;18(24):5294-9 - PubMed
  23. Endocrinology. 1992 Jan;130(1):249-56 - PubMed
  24. J Mol Endocrinol. 1994 Apr;12(2):215-24 - PubMed
  25. J Am Soc Nephrol. 1992 Aug;3(2):157-61 - PubMed
  26. Kidney Int. 1983 Apr;23(4):643-6 - PubMed

Publication Types